1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MAZE THERAPEUTICS INC.
Maze Therapeutics Inc.
XNAS: MAZE
48.47 -1.92 (-3.81%)
491.5K
XNAS Volume

XNAS 18 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The board meeting for Maze Therapeutics Inc is scheduled for today, for the purpose of Maze Therapeutics Inc Annual General Meeting for 2025 See details

Maze Therapeutics Inc - MAZE - stock price prediction, stock price target, analyst ratings from 12 analysts

Maze Therapeutics Inc has a share price target of US$ 60, revenue growth forecast of -99.3%, and profit growth estimate of -3937.8% for FY26, based on top 12 analyst calls.